80 FR 30473 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 102 (May 28, 2015)

Page Range		30473-30473
FR Document		2015-12900

Federal Register, Volume 80 Issue 102 (Thursday, May 28, 2015)

[Federal Register Volume 80, Number 102 (Thursday, May 28, 2015)]
[Notices]
[Page 30473]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-12900]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; GOMED: Grand Opportunity in Medications Development 
for Substance-Related Disorders (U01).
    Date: July 16, 2015.
    Time: 9:00 a.m. to 10:30 a.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Strategic Alliances for Medications Development to 
Treat Substance Use Disorders (R01) (PAR-13-334).
    Date: July 16, 2015.
    Time: 10:45 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA Translational Avant-Garde Award for Development 
of Medication to Treat Substance Use Disorders (UH2/UH3).
    Date: July 16, 2015.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: May 22, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12900 Filed 5-27-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 102 / Thursday, May 28, 2015 / Notices 30473

Agenda: To review and evaluate grant Date: June 25, 2015. 6001 Executive Blvd., Bethesda, MD 20892–
applications. Time: 8:00 a.m. to 5:00 p.m. 9550, (301) 451–3086, ruizjf@nida.nih.gov.
Place: Residence Inn Bethesda, 7335 Agenda: To review and evaluate grant Name of Committee: National Institute on
Wisconsin Avenue, Bethesda, MD 20814. applications. Drug Abuse Special Emphasis Panel;
Contact Person: Maria E. Davila-Bloom, Place: Doubletree Hotel Bethesda, Strategic Alliances for Medications
Ph.D., Scientific Review Officer, Review (Formerly Holiday Inn Select), 8120 Development to Treat Substance Use
Branch, DEA, NIDDK, National Institutes of Wisconsin Avenue, Bethesda, MD 20814. Disorders (R01) (PAR–13–334).
Health, Room 758, 6707 Democracy Contact Person: Nina Sidorova, Ph.D., Date: July 16, 2015.
Boulevard, Bethesda, MD 20892–5452, (301) Scientific Review Officer, Office of Scientific Time: 10:45 a.m. to 12:00 p.m.
594–7637, davila-bloomm@ Review, National Institute of General Medical Agenda: To review and evaluate grant
extra.niddk.nih.gov. Sciences, National Institutes of Health, 45 applications.
(Catalogue of Federal Domestic Assistance Center Drive, Room 3An.22, Bethesda, MD Place: Hilton Garden Inn Bethesda, 7301
Program Nos. 93.847, Diabetes, 20892, 301–402–2783, sidorova@ Waverly Street, Bethesda, MD 20814.
Endocrinology and Metabolic Research; mail.nih.gov. Contact Person: Jose F. Ruiz, Ph.D.,
93.848, Digestive Diseases and Nutrition (Catalogue of Federal Domestic Assistance Scientific Review Officer, Office of
Research; 93.849, Kidney Diseases, Urology Program Nos. 93.375, Minority Biomedical Extramural Affairs, National Institute on
and Hematology Research, National Institutes Research Support; 93.821, Cell Biology and Drug Abuse, NIH, Room 4228, MSC 9550,
of Health, HHS) Biophysics Research; 93.859, Pharmacology, 6001 Executive Blvd., Bethesda, MD 20892–
Physiology, and Biological Chemistry 9550, (301) 451–3086, ruizjf@nida.nih.gov.
Dated: May 22, 2015.
Research; 93.862, Genetics and Name of Committee: National Institute on
David Clary,
Developmental Biology Research; 93.88, Drug Abuse Special Emphasis Panel; NIDA
Program Analyst, Office of Federal Advisory Minority Access to Research Careers; 93.96, Translational Avant-Garde Award for
Committee Policy. Special Minority Initiatives, National Development of Medication to Treat
[FR Doc. 2015–12898 Filed 5–27–15; 8:45 am] Institutes of Health, HHS) Substance Use Disorders (UH2/UH3).
BILLING CODE 4140–01–P Date: July 16, 2015.
Dated: May 21, 2015. Time: 1:00 p.m. to 5:00 p.m.
Melanie J. Gray, Agenda: To review and evaluate
DEPARTMENT OF HEALTH AND Program Analyst, Office of Federal Advisory cooperative agreement applications.
Place: Hilton Garden Inn Bethesda, 7301
HUMAN SERVICES Committee Policy.
Waverly Street, Bethesda, MD 20814.
[FR Doc. 2015–12796 Filed 5–27–15; 8:45 am] Contact Person: Jose F. Ruiz, Ph.D.,
National Institutes of Health BILLING CODE 4140–01–P Scientific Review Officer, Office of
Extramural Affairs, National Institute on
National Institute of General Medical Drug Abuse, NIH, Room 4228, MSC 9550,
Sciences; Notice of Closed Meetings DEPARTMENT OF HEALTH AND 6001 Executive Blvd., Bethesda, MD 20892–
Pursuant to section 10(d) of the HUMAN SERVICES 9550, (301) 451–3086, ruizjf@nida.nih.gov.
Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance
amended (5 U.S.C. App.), notice is National Institutes of Health Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
hereby given of the following meetings. Institutes of Health, HHS)
The meetings will be closed to the National Institute on Drug Abuse;
public in accordance with the Notice of Closed Meetings Dated: May 22, 2015.
provisions set forth in sections Pursuant to section 10(d) of the Michelle Trout,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory
as amended. The grant applications and amended (5 U.S.C. App.), notice is Committee Policy.
the discussions could disclose hereby given of the following meetings. [FR Doc. 2015–12900 Filed 5–27–15; 8:45 am]
confidential trade secrets or commercial The meetings will be closed to the BILLING CODE 4140–01–P
property such as patentable material, public in accordance with the
and personal information concerning provisions set forth in sections
individuals associated with the grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND
applications, the disclosure of which as amended. The grant applications and HUMAN SERVICES
would constitute a clearly unwarranted the discussions could disclose
invasion of personal privacy. confidential trade secrets or commercial National Institutes of Health
Name of Committee: National Institute of property such as patentable material, Center for Scientific Review; Notice of
General Medical Sciences Initial Review and personal information concerning Closed Meetings
Group; Training and Workforce Development individuals associated with the grant
Subcommittee—D. applications, the disclosure of which Pursuant to section 10(d) of the
Date: June 25, 2015. would constitute a clearly unwarranted Federal Advisory Committee Act, as
Time: 8:00 a.m. to 5:00 p.m. amended (5 U.S.C. App.), notice is
Agenda: To review and evaluate grant
invasion of personal privacy.
applications. Name of Committee: National Institute on hereby given of the following meetings.
Place: Washington Marriott Wardman Park Drug Abuse Special Emphasis Panel; The meetings will be closed to the
Hotel, 2660 Woodley Road NW., Washington, GOMED: Grand Opportunity in Medications public in accordance with the
DC 20008. Development for Substance-Related provisions set forth in sections
Contact Person: Rebecca H. Johnson, Ph.D., Disorders (U01). 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Scientific Review Officer, Office of Scientific Date: July 16, 2015. as amended. The grant applications and
asabaliauskas on DSK5VPTVN1PROD with NOTICES

Review, National Institute of General Medical Time: 9:00 a.m. to 10:30 a.m. the discussions could disclose
Sciences, National Institutes of Health, 45 Agenda: To review and evaluate confidential trade secrets or commercial
Center Drive, Room 3An.12C, Bethesda, MD cooperative agreement applications.
20892, 301–594–2771, rebecca.johnson@
property such as patentable material,
Place: Hilton Garden Inn Bethesda, 7301
nih.gov. Waverly Street, Bethesda, MD 20814. and personal information concerning
Name of Committee: National Institute of Contact Person: Jose F. Ruiz, Ph.D., individuals associated with the grant
General Medical Sciences Special Emphasis Scientific Review Officer, Office of applications, the disclosure of which
Panel, Support of Competitive Research Extramural Affairs, National Institute on would constitute a clearly unwarranted
(SCORE). Drug Abuse, NIH, Room 4228, MSC 9550, invasion of personal privacy.

VerDate Sep<11>2014 18:18 May 27, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\28MYN1.SGM 28MYN1

Document Created: 2018-02-21 10:33:19
Document Modified: 2018-02-21 10:33:19

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 16, 2015.
FR Citation		80 FR 30473

80 FR 30473 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 102 (May 28, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health